loader from loading.io

Solidarity Fridays - Week 18

Psychedelics Today

Release Date: 07/31/2020

Solidarity Fridays - Week 25 show art Solidarity Fridays - Week 25

Psychedelics Today

In today’s Solidarity Fridays episode, Joe and Kyle discuss recent items in the news and dive into cannabis-assisted psychotherapy after Joe recently helped with his first session. They discuss Compass Pathways' projection that their upcoming stock price could be $14-$16 a share, giving them a possible valuation of as much as $544 million and the problem of having Peter Thiel as one of their leading investors, as it has recently come to surface that he met with white nationalists in 2016 and had good things to say about them. This, in addition to his concerning data-mining company, Palantir...

info_outline
Ash - CBD, Nootropics, and Micro1p show art Ash - CBD, Nootropics, and Micro1p

Psychedelics Today

In this episode, Joe interviews Ash: Netherlands-based psychedelic entrepreneur with his hands in many psychedelic spaces- drug manufacturing company Synergy Trading, nootropics company Cerebra Nootropics, and podcast, Shifty Perspective.   Ash talks about his path from trying San Pedro on a farm, to trying DMT and living on the road and in squats for years, to moving to Belgium from the UK, to finding his way into the world of CBD after a friend recommended it for his epileptic girlfriend at the time. When she went from 12 seizures a day to none within a month of starting regular...

info_outline
Solidarity Fridays - Week 24 show art Solidarity Fridays - Week 24

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle discuss several recent items in the news that further the advancement of psychedelics, including: Canadian company Havn Lifescience following Compass Pathways' lead and registering with the Canadian Securities Exchange under the symbol HAVN, Amsterdam-based psychedelic retreat company Synthesis announcing that leading Clinical Psychologist Dr. Rosalind Watts has joined their advisory board (which also includes Dr. Robin Carhart-Harris, who joined in November), European psychedelic-assisted psychotherapy company AWAKN Life Sciences Inc....

info_outline
Wade Davis - Ayahuasca and a New Hope for Colombia show art Wade Davis - Ayahuasca and a New Hope for Colombia

Psychedelics Today

In this episode, Joe interviews Wade Davis: Ph.D., Professor of Anthropology at the University of British Columbia, explorer, ethnobotanist, star of the recent documentary, "El Sendero de la Anaconda," and author of several books, including  bestseller The Serpent and the Rainbow, which was optioned for a movie, starring Bill Pullman and released by Universal Pictures in 1988. His new book, Magdalena: River of Dreams: A Story of Colombia, comes out on September 15th.  Wade discusses his history with Richard Evans Schultes, the strange phenomenon behind the growth of ayahuasca...

info_outline
Solidarity Fridays - Week 23 show art Solidarity Fridays - Week 23

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle discuss recent items in the news. They cover a new LSD microdose trial to study the effects of 5, 10, or 20 µg on acute pain, seeing how long participants could hold their hands in 37.4° F water. Led by researchers from Maastricht University with help from the Beckley Foundation, this is the first study of its kind since Eric Kast first studied the effects of LSD on acute pain in the 1960s, and could help lead to LSD being prescribed for acute pain over the more standard and very addictive and dangerous opioids. This leads towards the topic...

info_outline
Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens show art Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens

Psychedelics Today

In this episode, Joe and Kyle interview Sara Reed, MS, LMFT, creator of Mind's Eye Health Solutions, and Director of Psychedelic Services at the Behavioral Wellness Clinic in Connecticut. Reed talks about her path to psychedelics- from graduating with a masters in emerging family therapy and wanting to do research specifically with black Americans, to working with Dr. Monica Williams and eventually MAPS, to being selected as one of the therapists for a phase 3 MDMA-assisted psychotherapy trial (which focused on people of color), to making the transition from practicing with MDMA to ketamine...

info_outline
Solidarity Fridays - Week 22 show art Solidarity Fridays - Week 22

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle have, in Joe's words, "a wildly rambling show." They cover topics in the news, including MAPS' recent completion of their Capstone Campaign, a non-profit fundraising effort to fund the final research required to seek FDA approval of MDMA-assisted psychotherapy (through which they raised $30 million from several high-profile names), MindMed's new LSD-MDMA "candy flipping" phase 1 trial set to commence later this year, Representative Earl Blumenauer's (D-OR) fundraising efforts for legal psilocybin and Oregon's ballot initiative becoming a...

info_outline
Dr. LaMisha Hill - The Fight for Diversity, Inclusion, and Equity show art Dr. LaMisha Hill - The Fight for Diversity, Inclusion, and Equity

Psychedelics Today

In this episode, Joe interviews Dr. LaMisha Hill, licensed Counseling Psychologist, board member of the Alameda County Psychological Association, and Director of Multicultural Affairs for the Office of Diversity and Outreach at the University of California, San Francisco. Hill talks about how race and gender of underrepresented people come into play in the psychedelic sphere- in studies, professions, and even in people's consideration of psychedelics as a possible healer for them: how most psychology follows the same well-worn, Euro-centric, fairly western, mostly-for-well-off-college-students...

info_outline
Solidarity Fridays - Week 21 show art Solidarity Fridays - Week 21

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle sit down and discuss recent items in the news, including the passing of Tav Sparks; author, therapist, co-director of Grof Transpersonal Training, and creator of "Movie Yoga," and scientist Jordi Riba; one of the early pioneers of ayahuasca research and one of the first ever to bring it into the lab.  They discuss the ayahuasca episode of the new Netflix docuseries "Unwell," and 2 articles from Marijuana Moment: psychedelic activists in Oakland creating a guideline for plant medicine healing ceremonies and the new initiative to allow for...

info_outline
Jerry and Julie Brown - Healing Through Mystical Experience show art Jerry and Julie Brown - Healing Through Mystical Experience

Psychedelics Today

In this episode, Joe interviews Jerry and Julie Brown. Jerry (Ph.D.) is an author and activist, who served as founding professor of anthropology at Florida International University in Miami for 42 years. Julie (M.A.) is an author and integrative psychotherapist, who worked with cancer patients with a focus on guided imagery. Together, they are co-authors of The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity. They talk about their  on Psychedelics Today and inspiring studies: Walter Pahnke’s original psilocybin study at Marsh Chapel and Roland Griffiths’...

info_outline
 
More Episodes

In today's Solidarity Fridays episode, Joe and Kyle sit down to discuss recent topics in the news and analyze the ongoing debate of decriminalization vs. legalization. 

They first discuss the story of LSD chemist William Leonard Pickard, who was released from prison on July 27th due mostly to his age, health status and risk for contracting Covid-19, and while it's great that he's out, how it changes nothing about the conspiracy surrounding his arrest ("Halperngate") and the very questionable DEA claims of LSD availability decreasing by 95% after his imprisonment. 

They then talk about Denver mushroom grower Kole Milner, who is facing up to 20 years in prison and a $1 million fine, and all the complications surrounding state or city legality vs. federal legality, and how anyone in this space should be extremely careful about what personal information they share publicly, regardless of any perceived legal safety. 

This leads to a long discussion about decriminalization vs. legalization: the need for more conversation, what the model might look like for the US, what we can learn from Portugal, how Covid-related economic issues might influence things, the "my drug is better than your drug" issue with advertising, the problem with D.A.R.E.'s "scare you straight" model and the need for truth instead of manipulation, and how advertising and corporate profit incentives may come into play- does legality mean that companies will try to convince more people to use these powerful medicines irresponsibly?

Notable quotes

“It’s a false dichotomy to just say ‘decriminalization vs. legalization.’ As we say, decriminalization doesn’t necessarily mean anything. It can mean something for a municipality or a county or a state but it doesn’t necessarily mean that’s the case for the feds. And as soon as you’re crossing state lines, that’s when they can be really into it. But realistically, the DEA seems to have plenty of power to do whatever they want.” -Joe

“I remember a few years ago, I started making this comment: ‘Oh cool, so you want it to stay illegal so you can have your heady, farm-to-table LSD. Cute, but that’s not really how it works and there’s plenty of people getting hurt as a result of not having these controls in place.’ ...It just takes a couple high schoolers whipping up a shitty lab, or non-safety-oriented people just trying to make a quick buck to get a few people hurt. I want to be a libertarian, but I don’t necessarily trust people’s motives enough to fully be a libertarian. I feel like there needs to be incentive structures in place and regulation in place for a lot of things.” -Joe

“I remember them threatening us: ‘If you do this, we will come and arrest you.’ Like, whoa... What if you had somebody that was like, “Hey, psilocybin mushrooms- these were originally used in ceremonial contexts, they had these kinds of safety mechanisms built in place, and this is what’s going on, here are the risks and dangers, this is why you would want to do it in a situation like this, people are using it to find spiritual growth…” And I don’t know, is that more enticing to people? Like, “Oh. I’m really curious!” But at least when they would practice, hopefully, they’d be like, “Oh yea, remember, they told us to do it in this context” instead of being like “This is an illegal thing, we’re going to get arrested so let’s hide and do it in secrecy and not tell anybody about it because the police chief is going to kick down my door and arrest me and tell me I’m a bad person.” -Kyle

“Let’s just be fact-based. Like, ‘Ok, here are the laws, here’s where it comes from, here’s the history, here are the pluses and minuses, and here are the legal consequences at this point in time.’ I would just like the facts, you know? I don’t need to be manipulated. Because that’s all I felt it was- a manipulation of the truth and a manipulation of us. This is not science-based policy, and I think a lot of us now want science-based policy.” -Joe

Links

Breaking: LSD Chemist William Leonard Pickard to be Released From Prison

Lucid News: LSD Chemist And Psychedelic Icon William Leonard Pickard To Be Released From Prison

Erowid character vault on William Leonard Pickard

Erowid's article on Halperngate

LSD Use Up 56% Since 2015, According To Study by University of Cincinnati

Man Accused of Selling Mushrooms Faces Up to Twenty Years

Al Jazeera youtube stream: Are magic mushrooms going mainstream?

Support the show

Navigating Psychedelics